Rye MB - Search Results

1

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.

Søgaard CK, Moestue SA, Rye MB, Kim J, Nepal A, Liabakk NB, Bachke S, Bathen TF, Otterlei M, Hill DK. Søgaard CK, et al. Among authors: rye mb. Oncotarget. 2018 Jan 27;9(14):11752-11766. doi: 10.18632/oncotarget.24357. eCollection 2018 Feb 20. Oncotarget. 2018. PMID: 29545934 Free PMC article.

2

The statistical geometry of transcriptome divergence in cell-type evolution and cancer.

Liang C; FANTOM Consortium; Forrest AR, Wagner GP. Liang C, et al. Nat Commun. 2015 Jan 14;6:6066. doi: 10.1038/ncomms7066. Nat Commun. 2015. PMID: 25585899 Free article.

3

The Constrained Maximal Expression Level Owing to Haploidy Shapes Gene Content on the Mammalian X Chromosome.

Hurst LD, Ghanbarian AT, Forrest AR; FANTOM consortium; Huminiecki L. Hurst LD, et al. PLoS Biol. 2015 Dec 18;13(12):e1002315. doi: 10.1371/journal.pbio.1002315. eCollection 2015 Dec. PLoS Biol. 2015. PMID: 26685068 Free PMC article.

4

Discovery of molecular markers to discriminate corneal endothelial cells in the human body.

Yoshihara M, Ohmiya H, Hara S, Kawasaki S; FANTOM consortium; Hayashizaki Y, Itoh M, Kawaji H, Tsujikawa M, Nishida K. Yoshihara M, et al. PLoS One. 2015 Mar 25;10(3):e0117581. doi: 10.1371/journal.pone.0117581. eCollection 2015. PLoS One. 2015. PMID: 25807145 Free PMC article.

5

Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.

Carbajo D, Magi S, Itoh M, Kawaji H, Lassmann T, Arner E, Forrest AR, Carninci P, Hayashizaki Y, Daub CO; FANTOM consortium; Okada-Hatakeyama M, Mar JC. Carbajo D, et al. PLoS One. 2015 Dec 14;10(12):e0144176. doi: 10.1371/journal.pone.0144176. eCollection 2015. PLoS One. 2015. PMID: 26658111 Free PMC article.

6

Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.

Rye MB, Bertilsson H, Drabløs F, Angelsen A, Bathen TF, Tessem MB. Rye MB, et al. BMC Med Genomics. 2014 Aug 12;7:50. doi: 10.1186/1755-8794-7-50. BMC Med Genomics. 2014. PMID: 25115192 Free PMC article.

7

A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer.

Tessem MB, Bertilsson H, Angelsen A, Bathen TF, Drabløs F, Rye MB. Tessem MB, et al. Among authors: rye mb. PLoS One. 2016 Apr 21;11(4):e0153727. doi: 10.1371/journal.pone.0153727. eCollection 2016. PLoS One. 2016. PMID: 27100877 Free PMC article.

8

Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.

Hansen AF, Sandsmark E, Rye MB, Wright AJ, Bertilsson H, Richardsen E, Viset T, Bofin AM, Angelsen A, Selnæs KM, Bathen TF, Tessem MB. Hansen AF, et al. Among authors: rye mb. Oncotarget. 2016 Jul 5;7(27):42071-42085. doi: 10.18632/oncotarget.9817. Oncotarget. 2016. PMID: 27276682 Free PMC article.

9

A novel non-canonical Wnt signature for prostate cancer aggressiveness.

Sandsmark E, Hansen AF, Selnæs KM, Bertilsson H, Bofin AM, Wright AJ, Viset T, Richardsen E, Drabløs F, Bathen TF, Tessem MB, Rye MB. Sandsmark E, et al. Among authors: rye mb. Oncotarget. 2017 Feb 7;8(6):9572-9586. doi: 10.18632/oncotarget.14161. Oncotarget. 2017. PMID: 28030815 Free PMC article.

10

SFRP4 gene expression is increased in aggressive prostate cancer.

Sandsmark E, Andersen MK, Bofin AM, Bertilsson H, Drabløs F, Bathen TF, Rye MB, Tessem MB. Sandsmark E, et al. Among authors: rye mb. Sci Rep. 2017 Oct 27;7(1):14276. doi: 10.1038/s41598-017-14622-3. Sci Rep. 2017. PMID: 29079735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters